ABSTRACT

NIAID Biodefense Research Agenda for Category B and C Priority Pathogens   [open pdf - 1MB]

On October 22 and 23, 2002, the National Institute of Allergy and Infectious Diseases (NIAID) convened a Blue Ribbon Panel on Biodefense and Its Implications for Biomedical Research. This panel of experts was brought together to provide objective expertise on the Institute's future biodefense research agenda, as it relates to the NIAID Category B and C Priority Pathogens (Appendix 1). This Blue Ribbon Panel was asked to provide NIAID with the following guidance: Assess the current research sponsored by NIAID related to the development of effective measures to counter the health consequences of bioterrorism with a focus on the Category B and C priority pathogens; Identify research goals for the highest priority areas; Provide recommendations on the role of NIAID in achieving these priorities; and Provide recommendations on the current NIAID Category B and C Priority Pathogens list. NOTE: Although the NIAID list of Category A, B and C Priority Pathogens (Appendix 1) closely follows the CDC list of Category A, B and C Biological Diseases/Agents (Appendix 2), the NIAID list highlights specific pathogens identified as priorities for additional research efforts as part of the NIAID biodefense research agenda. 1

Publisher:
Date:
2003-01
Copyright:
Public Domain
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations